Henry Schein, Inc. (NASDAQ:HSIC) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned a consensus rating of “Hold” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and seven have issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $87.8462.

HSIC has been the subject of a number of research reports. Wall Street Zen downgraded shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 26th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Henry Schein in a report on Monday, May 4th. BTIG Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Thursday, June 11th. Mizuho decreased their price objective on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Finally, Wells Fargo & Company lifted their price objective on shares of Henry Schein from $76.00 to $87.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 25th.

Henry Schein Price Performance

HSIC stock opened at $79.92 on Friday. Henry Schein has a twelve month low of $61.94 and a twelve month high of $89.29. The company has a current ratio of 1.36, a quick ratio of 0.75 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $9.10 billion, a P/E ratio of 24.15, a PEG ratio of 1.54 and a beta of 0.82. The firm has a 50 day simple moving average of $75.96 and a 200-day simple moving average of $76.40.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. The business had revenue of $3.37 billion during the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, equities research analysts predict that Henry Schein will post 5.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Henry Schein news, Director William K. Daniel acquired 10,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $69.19 per share, with a total value of $691,900.00. Following the completion of the acquisition, the director directly owned 20,000 shares in the company, valued at $1,383,800. This trade represents a 100.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.89% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds have recently added to or reduced their stakes in HSIC. AQR Capital Management LLC lifted its stake in Henry Schein by 47.3% in the first quarter. AQR Capital Management LLC now owns 30,402 shares of the company’s stock valued at $2,071,000 after buying an additional 9,756 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Henry Schein by 1.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock valued at $1,155,000 after buying an additional 229 shares during the last quarter. Acadian Asset Management LLC bought a new stake in Henry Schein in the first quarter valued at $676,000. Cetera Investment Advisers lifted its stake in Henry Schein by 12.9% in the second quarter. Cetera Investment Advisers now owns 5,561 shares of the company’s stock valued at $406,000 after buying an additional 637 shares during the last quarter. Finally, First Trust Advisors LP lifted its stake in Henry Schein by 0.8% in the second quarter. First Trust Advisors LP now owns 221,130 shares of the company’s stock valued at $16,154,000 after buying an additional 1,669 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.